Forxiga CKD Japan Post-Marketing Surveillance (PMS)

Trial Identifier: D169AC00007
Sponsor: AstraZeneca
NCTID:: NCT05306210
Start Date: April 2022
Primary Completion Date: April 2025
Study Completion Date: April 2025
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Akita, Japan
Japan Fukui, Japan
Japan Ishikawa, Japan
Japan Iwate, Japan
Japan Kumamoto, Japan
Japan Nagasaki, Japan
Japan Nara, Japan
Japan Niigata, Japan
Japan Oita, Japan
Japan Shiga, Japan
Japan Shimane, Japan
Japan Wakayama, Japan
Japan Yamanashi, Japan